These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 9641474

  • 1. K-ATP-blocking diuretic PNU-37883A reduces plasma renin activity in dogs.
    Humphrey SJ, Ludens JH.
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):894-903. PubMed ID: 9641474
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular effects of the K-ATP channel blocker U-37883A and structurally related morpholinoguanidines.
    Humphrey SJ, Smith MP, Cimini MG, Buchanan LV, Gibson JK, Khan SA, Meisheri KD.
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):247-60. PubMed ID: 8803957
    [Abstract] [Full Text] [Related]

  • 3. Interaction of the diuretics torasemide and U-37883A with the K(ATP) channel in rat isolated aorta.
    Löffler-Walz C, Quast U.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):230-7. PubMed ID: 9750009
    [Abstract] [Full Text] [Related]

  • 4. K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries.
    Ploug KB, Boni LJ, Baun M, Hay-Schmidt A, Olesen J, Jansen-Olesen I.
    Br J Pharmacol; 2008 May; 154(1):72-81. PubMed ID: 18332850
    [Abstract] [Full Text] [Related]

  • 5. Effects of K-ATP blocking guanidine diuretics during experimental kaliuresis in rats and dogs.
    Humphrey SJ.
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17(8):519-28. PubMed ID: 8749224
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological Profile of U-37883A, a Channel Blocker of Smooth Muscle-Type ATP-Sensitive K Channels.
    Teramoto N.
    Cardiovasc Drug Rev; 2006 Oct; 24(1):25-32. PubMed ID: 16939631
    [Abstract] [Full Text] [Related]

  • 7. Diuretic activity of N'-disubstituted morpholinoguanidine analogs of U-37883A in rats and dogs.
    Humphrey SJ, Ludens JH, Perricone SC, Skaletzky LL, Graham BE, Zins GR.
    Methods Find Exp Clin Pharmacol; 1995 May; 17(4):255-66. PubMed ID: 7475512
    [Abstract] [Full Text] [Related]

  • 8. Molecular analysis of the subtype-selective inhibition of cloned KATP channels by PNU-37883A.
    Kovalev H, Quayle JM, Kamishima T, Lodwick D.
    Br J Pharmacol; 2004 Mar; 141(5):867-73. PubMed ID: 14757705
    [Abstract] [Full Text] [Related]

  • 9. Renal and vascular effects of chemically distinct ATP-sensitive K+ channel blockers in rats.
    Ludens JH, Clark MA, Smith MP, Humphrey SJ.
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):404-9. PubMed ID: 7769805
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and diuretic activity of alkyl- and arylguanidine analogs of N,N'-dicyclohexyl-4-morpholinecarboxamidine in rats and dogs.
    Perricone SC, Humphrey SJ, Skaletzky LL, Graham BE, Zandt RA, Zins GR.
    J Med Chem; 1994 Oct 28; 37(22):3693-700. PubMed ID: 7966129
    [Abstract] [Full Text] [Related]

  • 11. The natriuretic activity of the K+ channel blocker U-37883A displays an ADH-dependence.
    Clark MA, Lawson JA, Ludens JH.
    Methods Find Exp Clin Pharmacol; 1998 Mar 28; 20(2):115-23. PubMed ID: 9604853
    [Abstract] [Full Text] [Related]

  • 12. Potassium diet as a determinant for the renal response to systemic potassium channel modulation in anesthetized rats.
    Vallon V, Kirschenmann D, Brenner I, Albinus M, Osswald H.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug 28; 358(2):245-52. PubMed ID: 9750011
    [Abstract] [Full Text] [Related]

  • 13. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
    Cui Y, Tinker A, Clapp LH.
    Br J Pharmacol; 2003 May 28; 139(1):122-8. PubMed ID: 12746230
    [Abstract] [Full Text] [Related]

  • 14. K+ loading, but not Na+ loading, and blockade of ATP-sensitive K+ channels augment renal kallikrein secretion.
    Fujita T, Hayashi I, Kumagai Y, Inamura N, Majima M.
    Immunopharmacology; 1999 Oct 15; 44(1-2):169-75. PubMed ID: 10604541
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.
    Wellman GC, Barrett-Jolley R, Köppel H, Everitt D, Quayle JM.
    Br J Pharmacol; 1999 Oct 15; 128(4):909-16. PubMed ID: 10556925
    [Abstract] [Full Text] [Related]

  • 16. Eukaliuric diuresis and natriuresis in response to the KATP channel blocker U37883A: micropuncture studies on the tubular site of action.
    Huang DY, Osswald H, Vallon V.
    Br J Pharmacol; 1999 Aug 15; 127(8):1811-8. PubMed ID: 10482911
    [Abstract] [Full Text] [Related]

  • 17. Guanidine derivative U-37883A, inhibits mitochondrial K+ uniport.
    Szewczyk A, Wójcik G, Jabłonowska A, Nałecz.
    Pol J Pharmacol; 1995 Aug 15; 47(4):339-44. PubMed ID: 8616514
    [Abstract] [Full Text] [Related]

  • 18. Effects of a K+ channel blocker on glomerular filtration rate and electrolyte excretion in conscious rats.
    Ludens JH, Clark MA, Lawson JA.
    J Pharmacol Exp Ther; 1995 Jun 15; 273(3):1375-81. PubMed ID: 7791110
    [Abstract] [Full Text] [Related]

  • 19. Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
    Tomoda T, Yunoki T, Naito S, Ito Y, Teramoto N.
    Eur J Pharmacol; 2005 Nov 07; 524(1-3):1-10. PubMed ID: 16242124
    [Abstract] [Full Text] [Related]

  • 20. 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.
    Meisheri KD, Humphrey SJ, Khan SA, Cipkus-Dubray LA, Smith MP, Jones AW.
    J Pharmacol Exp Ther; 1993 Aug 07; 266(2):655-65. PubMed ID: 8355199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.